日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2.

优化人源单克隆抗体以更好地中和 SARS-CoV-2

Wang Qian, Guo Yicheng, Casner Ryan G, Yu Jian, Nair Manoj S, Ho Jerren, Reddem Eswar R, Mellis Ian A, Wu Madeline, Tzang Chih-Chen, Hong Hsiang, Huang Yaoxing, Shapiro Lawrence, Liu Lihong, Ho David D

Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking

通过构象锁定中和所有当前关注的SARS-CoV-2变异株的抗体

Liu, Lihong; Casner, Ryan G; Guo, Yicheng; Wang, Qian; Iketani, Sho; Chan, Jasper Fuk-Woo; Yu, Jian; Dadonaite, Bernadeta; Nair, Manoj S; Mohri, Hiroshi; Reddem, Eswar R; Yuan, Shuofeng; Poon, Vincent Kwok-Man; Chan, Chris Chung-Sing; Yuen, Kwok-Yung; Sheng, Zizhang; Huang, Yaoxing; Bloom, Jesse D; Shapiro, Lawrence; Ho, David D

First crystal structures of 1-deoxy-D-xylulose 5-phosphate synthase (DXPS) from Mycobacterium tuberculosis indicate a distinct mechanism of intermediate stabilization

结核分枝杆菌1-脱氧-D-木酮糖5-磷酸合酶(DXPS)的首个晶体结构揭示了一种独特的中间体稳定机制。

Gierse, Robin M; Oerlemans, Rick; Reddem, Eswar R; Gawriljuk, Victor O; Alhayek, Alaa; Baitinger, Dominik; Jakobi, Harald; Laber, Bernd; Lange, Gudrun; Hirsch, Anna K H; Groves, Matthew R